A Study of IBI362 in Chinese Patients With Type 2 Diabetes
Clinical trial NCT04965506 · COMPLETED
Trial details
- NCT number
- NCT04965506
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-06
- Primary completion
- 2022-04-28
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.